evolutionari
perspect
cellular
mediat
hemostasi
immun
defens
alway
separ
invertebr
cell
type
call
hemocyt
protect
host
invad
microb
cell
also
prevent
blood
ie
hemolymph
loss
upon
injuri
trigger
coagul
highli
develop
speci
hemostasi
immun
respons
divid
leukocyt
resum
immun
respons
function
platelet
maintain
hemostasi
decad
two
system
thought
act
independ
concept
recent
challeng
emerg
evid
suggest
boundari
coagul
immun
defens
actual
clearcut
origin
suppos
new
concept
involv
immun
cell
hemostasi
term
immunothrombosi
recent
propos
assum
function
innat
immun
cell
thrombosi
hand
import
role
platelet
immun
respons
becom
appar
bizzozero
discov
platelet
third
morpholog
element
blood
elucid
function
cell
hemostasi
thrombosi
long
time
platelet
granul
content
thought
mainli
mediat
activ
coagul
system
recruit
platelet
stop
blood
loss
upon
injuri
unwant
platelet
activ
note
occur
respons
intern
injuri
exampl
denud
eros
endotheli
surfac
ruptur
atherosclerot
plaqu
consequ
platelet
assum
respons
lethal
step
cardiovascular
diseas
unstabl
thrombi
occlud
small
vessel
therebi
compromis
oxygen
suppli
target
organ
nevertheless
platelet
involv
far
process
respond
interact
far
trigger
initi
thought
besid
central
role
hemostasi
platelet
assist
modul
inflammatori
reaction
immun
respons
direct
interact
leukocyt
well
endotheli
cell
via
releas
solubl
inflammatori
mediat
enhanc
recruit
leukocyt
trigger
activ
platelet
also
express
surfac
receptor
lectin
integrin
tolllik
receptor
tlr
allow
directli
interact
sever
pathogen
moreov
express
fc
receptor
recogn
immunocomplex
thu
platelet
activ
occur
respons
injuri
limit
hemostat
process
also
modul
host
respons
viru
surviv
therefor
potenti
immunemodulatori
side
effect
consid
antiplatelet
therapi
date
role
platelet
respons
invad
pathogen
fulli
understood
interact
seem
benefici
host
due
upregul
immun
respons
howev
platelet
interact
invad
pathogen
also
specul
benefit
viru
bacteria
platelet
provid
shelter
leukocyt
antivir
agent
antibiot
moreov
sticki
platelet
might
attenu
interact
facilit
infect
similar
mechan
recent
describ
platelet
interact
circul
tumor
cell
review
aim
summar
current
knowledg
platelet
interact
differ
type
virus
viral
impact
platelet
activ
plateletmedi
modul
innat
adapt
immun
respons
platelet
erythrocyt
second
abund
cell
popul
blood
normal
platelet
count
rang
platelet
per
microlit
thrombocytopenia
repres
drop
platelet
count
caus
either
decreas
platelet
product
increas
platelet
destruct
associ
increas
bleed
risk
thrombocytopenia
frequent
follow
viral
infect
virus
use
varieti
distinct
strategi
decreas
level
circul
platelet
differ
mechan
viru
infect
interfer
platelet
product
might
trigger
platelet
destruct
summar
first
chapter
figur
virusmedi
thrombocytopenia
often
multifactori
differ
viru
infect
mechan
virus
trigger
thrombocytopenia
separ
discuss
promin
virus
overview
receptor
involv
direct
interact
depict
figur
platelet
produc
bone
marrow
megakaryocyt
develop
hematopoiet
stem
cell
megakaryocyt
first
undergo
linag
commit
follow
endomitosi
result
polyploidi
polyploidi
state
one
cell
compris
multipl
set
chromosom
repres
import
step
megakaryopoiesi
endoplasmat
matur
megakaryocyt
form
proplatelet
bud
thousand
platelet
microparticl
blood
stream
megakaryopoiesi
trigger
varieti
cytokin
eg
gmcsf
thrombopoietin
tpo
import
nevertheless
tpo
trigger
megakaryocyt
develop
also
fulfil
import
role
maintain
stem
cell
virus
modul
platelet
product
variou
step
develop
abl
influenc
cytokin
profil
host
result
alter
tpo
product
liver
exampl
includ
simian
immunodefici
viru
siv
trigger
tpo
product
via
upregul
tumor
growth
factor
tgf
human
herp
viru
interfer
tpoinduc
megakaryocyt
coloni
format
human
herp
viru
impair
surviv
differenti
megakaryocyt
virus
also
directli
interfer
tpo
product
destruct
liver
tissu
shown
hepat
c
viru
hcv
result
drop
tpo
product
result
delay
megakaryocyt
develop
decreas
platelet
product
virus
infect
bone
marrow
stromal
cell
hematopoiet
stem
cell
result
alter
cytokin
product
decreas
number
progenitor
cell
therebi
disturb
hematopoiesi
human
immunodefici
viru
hiv
cytomegaloviru
cmv
hcv
known
replic
megakaryocyt
mani
virus
interact
megakaryocyt
modul
prolifer
function
viral
infect
megakaryocyt
increas
apoptosi
decreas
matur
ploidi
megakaryocyt
moreov
virusinfect
megakaryocyt
shown
express
less
surfac
cmpl
receptor
tpo
overview
differ
mechan
virus
interfer
platelet
product
depict
figur
thrombocytopenia
induc
decreas
platelet
product
observ
later
stage
infect
rapidli
induc
thrombocytopenia
respons
viral
infect
mediat
via
enhanc
platelet
destruct
rapid
way
platelet
destruct
occur
via
direct
interact
platelet
virus
interact
occur
via
varieti
receptor
mainli
mediat
integrin
surfac
lectin
tlr
see
figur
platelet
bind
cmv
via
trigger
platelet
activ
degranul
result
enhanc
platelet
interact
neutrophil
encephalomyocard
viru
emcv
recent
shown
interact
platelet
also
lead
platelet
degranul
direct
interact
platelet
fragment
subsequ
get
phagocyt
neutrophil
therebi
contribut
drop
platelet
count
rotaviru
util
collagen
receptor
gpiaiia
bind
platelet
hantaviru
adenovirus
interact
platelet
via
fibrinogen
receptor
gpiibiiia
howev
gpiibiiia
seem
uniqu
receptor
interact
inhibit
gpiibiiia
alter
platelet
intern
adenovirus
addit
hantavirusinfect
endotheli
cell
bind
quiescent
platelet
via
gpiibiiia
result
platelet
activ
clearanc
might
also
influenc
vascular
permeabl
gpiibiiia
abund
platelet
integrin
display
bidirect
signal
function
insideout
signal
posit
regul
variou
platelet
agonist
mediat
intracellular
interact
biochem
reaction
regul
gpiibiiia
affin
intracellular
process
trigger
gpiibiiia
activ
complex
includ
recruit
talin
separ
gpiib
gpiiia
subunit
kindlin
involv
gpiibiiia
activ
independ
talin
recruit
g
protein
subunit
directli
bind
cytoplasm
domain
gpiiia
promot
ligand
bind
gpiibiiia
outsidein
signal
via
receptor
bind
promot
actin
polymer
platelet
spread
therebi
enhanc
viru
attach
endotheli
cell
also
promot
platelet
clearanc
viru
ebv
interact
platelet
occur
via
complement
receptor
hiv
dengu
viru
activ
platelet
bind
lectin
receptor
ctype
lectin
domain
famili
cellspecif
intercellular
adhes
nonintegrin
dcsign
platelet
andor
megakaryocyt
interact
hiv
envelop
protein
via
chemokin
receptor
type
via
chemokin
motif
ligand
ccl
rant
howev
chang
coreceptor
usag
mani
year
infect
receptor
chang
repres
switch
platelet
activ
late
stage
diseas
addit
platelet
express
coxsacki
virusspecif
coxsackieadenoviru
receptor
car
hcv
interact
platelet
via
collagen
receptor
gpvi
direct
interact
often
result
platelet
activ
adhes
activ
platelet
leukocyt
platelet
bind
neutrophil
trigger
phagocytosi
platelet
platelet
activ
promot
platelet
clearanc
spleen
liver
howev
platelet
activ
direct
interact
virus
host
defens
mechan
respons
viral
infect
also
lead
platelet
activ
exampl
mani
viral
infect
lead
system
inflamm
turn
trigger
platelet
activ
decreas
platelet
life
span
among
other
influenza
viru
rhinoviru
cmv
infect
result
upregul
cytokin
interleukin
target
cell
platelet
activ
cytokin
lead
interact
foster
leukocyt
endotheli
activ
amplifi
platelet
activ
enhanc
clearanc
splenic
macrophag
kupffer
cell
liver
monocyt
encount
dengu
viru
exampl
start
gener
platelet
activ
factor
paf
lipid
mediat
trigger
platelet
activ
lead
enhanc
apoptosi
platelet
acceler
platelet
clearanc
secondari
dengu
infect
sever
viru
infect
activ
coagul
cascad
via
induct
tissu
factor
tf
express
target
cell
gener
thrombin
activ
coagul
cascad
caus
platelet
activ
subsequ
clearanc
via
proteas
activ
receptor
par
signal
par
platelet
endotheli
cell
leukocyt
import
modul
viral
infect
modul
innat
immun
respons
exert
posit
neg
effect
tlrdepend
respons
platelet
also
recogn
viral
particl
coat
immunoglobulin
via
receptor
result
fc
receptormedi
platelet
activ
aggreg
platelet
clearanc
platelet
activ
depend
igg
gpiibiiia
engag
involv
adp
thromboxan
feedback
mechan
caus
platelet
aggreg
enhanc
furthermor
blymphocyt
product
antibodi
virus
shown
interfer
platelet
surviv
antibodi
usual
target
surfac
glycoprotein
virus
show
crossreact
platelet
surfac
intergrin
gpiibiiia
gpibixv
call
idiopath
thrombocytopen
purpura
itp
platelet
autoantibodyinduc
thrombocytopenia
describ
hcv
hiv
cmv
ebv
hantaviru
varicella
zoster
viru
herp
virus
sever
acut
respiratori
syndrom
coronaviru
addit
platelet
destruct
respons
viral
infect
occur
due
disturb
portal
vein
pressur
enhanc
sequestr
platelet
enlarg
spleen
case
hcv
infect
thrombocytopenia
respons
viral
infect
often
multifactori
viral
hepat
thrombocytopenia
caus
plateletspecif
glycoprotein
antibodi
well
immun
complex
bound
platelet
surfac
case
hcv
thrombocytopenia
revers
use
select
thrombin
receptor
agonist
indic
coagul
inflamm
platelet
activ
play
role
hcvinduc
decreas
platelet
count
hcv
also
indirectli
affect
megakaryopoiesi
hcvinduc
liver
dysfunct
result
decreas
tpo
product
turn
result
impair
platelet
product
bone
marrow
recoveri
tpo
level
increas
platelet
count
follow
success
liver
transplant
hcvinfect
individu
emphas
import
mechan
hcvinduc
thrombocytopenia
moreov
portal
hypertens
lead
platelet
activ
shorten
platelet
surviv
due
increas
splenic
platelet
sequestr
howev
treatment
aim
revers
portal
hypertens
alway
correct
thrombocytopenia
human
immunodefici
virusinduc
thrombocytopenia
caus
multipl
mechan
effect
hiv
megakaryocyt
develop
recent
review
ref
brief
hiv
result
impair
surviv
bone
marrow
megakaryocyt
precursor
hiv
also
decreas
number
activ
human
progenitor
cell
decreas
megakaryocyt
matur
ploidi
hiv
surfac
glycoprotein
lead
increas
megakaryocyt
apoptosi
vitro
due
increas
downregul
proliferationinduc
ligand
tumor
necrosi
factor
ligand
superfamili
member
interact
express
immatur
megakaryocyt
also
express
lead
infect
furthermor
hiv
infect
megakaryocyt
lead
reduc
tpo
receptor
cmpl
express
dengu
viru
infect
platelet
product
impair
suppress
megakaryopoiesi
via
infect
hematopoiet
progenitor
cell
indirectli
via
alter
cytokin
level
bone
marrow
due
impair
stromal
cell
function
platelet
patient
dengu
infect
present
sign
activ
mitochondri
dysfunct
enhanc
apoptosi
may
contribut
genesi
thrombocytopenia
enhanc
destruct
platelet
occur
due
crossreact
platelet
antidengu
viru
antibodi
dengu
virusinduc
antinonstructur
induc
complementmedi
lysi
platelet
therebi
acceler
thrombocytopenia
also
activ
endotheli
cell
lead
increas
vascular
permeabl
platelet
activ
dengu
virusinfect
patient
show
increas
level
eselectin
endotheli
cell
surfac
promot
adhes
clearanc
platelet
well
enhanc
activ
coagul
cascad
arenavirus
infect
either
lymphocyt
choriomening
viru
lcmv
junin
viru
result
thrombocytopenia
decreas
agonistinduc
platelet
respons
mice
consequ
platelet
deplet
lmcvinfect
mice
result
lethal
hemorrhag
anemia
effect
caus
diminish
platelet
respons
rather
sole
drop
platelet
count
underli
mechan
alter
platelet
product
reduc
platelet
reactiv
found
reli
virusinduc
product
interferon
ifn
junin
viru
mainli
infect
cell
megakaryocyt
impair
proplatelet
format
platelet
releas
via
receptor
signal
receptor
signal
repres
import
paracrin
repressor
megakaryopoiesi
directli
inhibit
tpoinduc
signal
induct
suppressor
cytokin
signal
induct
synthetas
oa
deceas
nuclear
factor
erythroid
express
hantaviru
directli
interact
activ
platelet
via
gpiibiiia
infect
megakaryocyt
hantaviru
induc
upregul
human
leukocyt
antigen
hla
class
molecul
megakaryocyt
surfac
lead
cytotox
tlymphocytemedi
destruct
megakaryocyt
virus
also
possess
enzym
modul
platelet
function
exampl
influenza
viru
exhibit
neuraminidas
sialidas
hydrolys
termin
sialic
acid
residu
host
cell
receptor
therebi
decreas
life
span
platelet
target
platelet
rapid
clearanc
liver
spleen
anoth
exampl
mycovir
neuraminidas
shown
reduc
platelet
life
span
cleav
sialic
acid
platelet
membran
besid
effect
platelet
live
span
neuroaminidas
alter
megakaryocyt
ploidi
well
morpholog
size
platelet
newcastl
viru
directli
disrupt
platelet
cell
membran
result
platelet
lysi
human
parvoviru
reproduc
megakaryocyt
trigger
drop
platelet
count
via
platelet
activ
despit
effect
tpo
gener
direct
interact
nonhuman
siv
platelet
result
aggreg
format
promot
monocyt
differenti
inflammatori
phenotyp
furthermor
platelet
activ
trigger
clearanc
platelet
platelet
becom
recogn
macrophag
spleen
lead
rapid
drop
platelet
count
current
unclear
extent
virus
host
could
benefit
thrombocytopenia
suggest
downregul
hematopoiesi
exampl
dengu
viru
infect
might
protect
role
microenviron
limit
injuri
elimin
infect
cell
direct
interact
platelet
virus
observ
variou
viral
infect
could
proven
vitro
studi
interact
lead
platelet
activ
result
enhanc
platelet
clearanc
elimin
virusladen
platelet
also
contribut
clearanc
viru
particl
overview
differ
mechan
platelet
interfer
viru
infect
given
figur
platelet
activ
respons
direct
indirect
interact
virus
result
platelet
activ
degranul
platelet
provid
plateletmedi
host
defens
mechan
contain
kinocidin
microbicid
protein
import
antivir
host
defens
kinocidin
immunemodulatori
function
includ
chemotaxi
activ
variou
immun
cell
differenti
host
pathogen
cell
membran
distinct
microbi
spectra
differ
ph
condit
thrombin
produc
upon
inflamm
injuri
proteolyt
cleav
kinocidin
platelet
antimicrobi
peptid
result
cleavag
product
stronger
broader
rang
antimicrobi
activ
pathogen
also
cleav
kinocidin
distinct
site
potenti
result
inactiv
abund
platelet
kinocidin
platelet
factor
releas
blood
stream
upon
tissu
injuri
inflamm
oxid
stress
pathogen
stimul
interact
identifi
broadspectrum
inhibitor
suppress
infect
tlymphocyt
via
steric
inhibit
bind
proxim
bind
site
import
chemokin
releas
viral
infect
host
defens
identifi
major
hivsuppress
factor
produc
cytotox
tlymphocyt
also
plateletderiv
could
play
role
process
current
unclear
whether
effect
inhibit
hiv
infect
due
perturb
viral
envelop
andor
due
competit
bind
receptor
primarili
hiv
abl
decreas
releas
platelet
therebi
directli
counteract
antivir
respons
platelet
mainli
plateletderiv
releas
variou
cell
type
inde
varieti
virus
shown
induc
releas
review
ref
involv
viral
lung
diseas
repres
import
chemokin
develop
resolut
pulmonari
leukocyt
respons
influenza
viru
infect
mice
interact
receptor
provid
antiapoptot
signal
macrophag
influenza
viru
infect
import
cell
surviv
viral
infect
multifacet
role
hcv
infect
modul
inflammatori
reaction
tissu
injuri
also
induc
upregul
tlymphocyt
helper
cell
type
upon
activ
platelet
releas
shown
neutral
varieti
virus
platelet
antimicrobi
peptid
kngrklcldlqaali
aalykkkiikkl
platelet
molecul
also
demonstr
potent
reduc
viral
titer
vaccinia
viru
plateletderiv
antimicrobi
peptid
exampl
thymosin
beta
cleavag
product
antimicrobi
peptid
fibrinopeptid
b
thrombocidin
directli
act
viral
infect
could
prevent
host
bacteri
superinfect
highest
amount
serotonin
blood
store
platelet
dens
granul
also
releas
upon
platelet
activ
serotonin
found
import
mediat
liver
regener
also
mediat
earli
tlymphocyt
stimul
platelet
degranul
result
surfac
express
pselectin
part
inner
membran
fuse
outer
platelet
membran
upon
granul
exocytosi
pselectin
interact
counterreceptor
pselectin
glycoprotein
constitut
express
surfac
leukocyt
platelet
interact
leukocyt
mediat
immun
respons
viral
infect
direct
interact
platelet
lead
activ
leukocyt
result
enhanc
phagocytosi
reactiv
oxygen
product
neutrophil
well
neutrophil
extracellular
trap
format
interact
result
increas
activ
differenti
boost
monocyt
surfac
express
tf
format
microparticl
respons
cmv
emcv
interact
result
stimul
tlr
trigger
platelet
degranul
rapid
direct
interact
platelet
neutrophil
note
platelet
shown
decreas
emcv
count
fashion
contribut
host
surviv
prothrombot
consequ
platelet
emcv
interact
could
observ
platelet
recruit
dendrit
cell
site
injuri
infect
product
releas
platelet
promot
matur
dendrit
cell
enhanc
antigen
present
capac
interact
modul
leukocyt
function
acceler
ligand
bind
platelet
express
secret
solubl
therebi
trigger
host
respons
boost
inflamm
platelet
directli
interact
tlymphocyt
blymphocyt
modul
function
via
direct
interact
well
solubl
mediat
plateletreleas
enhanc
pro
antiinflammatori
cytokin
product
tlymphocyt
repres
import
mediat
tcell
differenti
lead
increas
regulatori
tlymphocyt
limit
differenti
platelet
addit
enhanc
tlymphocytemedi
germin
center
format
independ
upregul
adenoviru
specif
igg
via
bind
iggcoat
virus
caus
platelet
express
turn
prime
protect
tcellmedi
immun
platelet
mice
infect
lymphocyt
choriomening
viru
found
respons
effici
cytotox
tcell
respons
depend
platelet
gpiiia
tlymphocyt
interact
platelet
also
result
activ
platelet
amplifi
releas
hepat
viru
b
hbv
infect
mice
platelet
shown
respons
intrahepat
accumul
virusspecif
cytotox
tlymphocyt
mediat
cytotox
tcell
influx
liver
tissu
via
pselectin
enhanc
viral
clearanc
also
tissu
damag
shown
lcmv
infect
model
drop
platelet
count
lead
necrot
destruct
splenocyt
affect
innat
adapt
immun
lead
uncontrol
lcmv
replic
indic
platelet
necessari
maintain
splenocyt
surviv
date
remain
unclear
interact
benefici
host
viru
potenti
advers
effect
platelet
viral
infect
summar
figur
hiv
exampl
intern
platelet
result
shelter
viru
particl
host
immun
system
allow
dissemin
throughout
entir
bodi
review
ref
moreov
respons
hiv
interact
platelet
becom
activ
releas
result
recruit
highli
suscept
target
cell
like
tlymphocyt
monocyt
demonstr
influenza
viru
platelet
serv
carrier
viru
circul
also
hcv
shown
take
advantag
platelet
safe
transport
system
reach
liver
platelet
activ
enhanc
interact
platelet
liver
cell
interact
prolong
time
potenti
infect
liver
tissu
viru
virusmedi
activ
platelet
subsequ
plateletderiv
cytokin
releas
protect
host
may
also
unwant
implic
host
sever
report
indic
broadspectrum
suppressor
hiv
infect
one
report
indic
platelet
also
facilit
human
macrophag
infect
potenti
viru
replic
furthermor
shown
mediat
liver
fibrosi
experiment
mous
model
indic
chemokin
could
play
role
plateletmedi
acceler
hepatitisinduc
liver
fibrosi
plateletderiv
serotonin
result
delay
entri
activ
cytotox
tlymphocyt
liver
slow
viru
control
support
viru
persist
liver
result
aggrav
virusinduc
immunopatholog
megakaryocyt
infect
subsequ
modul
platelet
function
cmv
specul
reason
graft
failur
allergen
bone
marrow
transplant
primari
secondari
hemostasi
work
tightli
togeth
imbal
either
system
result
impair
function
activ
coagul
cascad
observ
variou
viru
infect
includ
hiv
dengu
ebola
viru
infect
might
provid
host
defens
mechan
limit
pathogen
dissemin
chang
activ
coagul
cascad
modul
platelet
count
function
also
observ
viral
infect
lead
increas
risk
dissemin
vascular
coagul
dic
deep
vein
thrombosi
dvt
thrombosi
hemorrhag
infect
patient
thrombocytopenia
common
result
viral
infect
associ
increas
bleed
risk
approxim
hiv
posit
patient
patient
acquir
immunodefici
syndrom
aid
suffer
thrombocytopenia
lead
sever
bleed
patient
mani
viral
infect
platelet
function
aggreg
respons
differ
agonist
diminish
caus
bleed
complic
viral
hemorrhag
fever
vhf
vhf
outbreak
lead
death
thousand
peopl
everi
year
caus
differ
envelop
rna
virus
includ
arenavirida
eg
lassa
viru
bunyaviridea
eg
hantaviru
filiovirida
eg
marburg
ebola
viru
flavivirida
eg
dengu
viru
note
recent
shown
reduct
platelet
count
necessari
hemorrhag
occur
indic
low
percentag
platelet
suffici
maintain
vascular
integr
lcmv
model
demonstr
even
sever
thrombocytopen
mice
develop
local
hemorrhag
site
inflamm
lcmvdepend
bleed
result
signalinginduc
platelet
dysfunct
mice
lack
function
receptor
show
less
sever
anemia
hemorrhag
due
restor
platelet
aggreg
capac
lcmv
infect
indic
platelet
dysfunct
tremend
effect
thrombocytopenia
patholog
note
mani
vhf
virus
inhibit
platelet
function
junin
viru
caus
argentinean
hemorrhag
fever
induc
signalingdepend
decreas
platelet
product
function
ebola
viru
also
induc
increas
correl
increas
fatal
ebola
infect
trigger
tf
express
associ
ebola
hemorrhag
fever
hantaviru
lassaviru
also
abrog
platelet
respons
via
plasmamedi
platelet
inhibit
andor
direct
interact
although
thrombocytopenia
frequent
observ
patient
dengu
infect
bleed
rare
howev
bleed
occur
associ
high
mortal
risk
note
dengu
virusinfect
patient
platelet
count
predict
bleed
risk
howev
system
platelet
activ
might
contribut
procoagulatori
state
patient
frequent
develop
dic
moreov
elev
platelet
activ
associ
plasma
leakag
influenza
infect
enhanc
activ
circul
platelet
result
increas
event
thrombosi
line
observ
platelet
dysfunct
increas
risk
hemorrhag
therefor
mortal
demonstr
pharmacolog
inhibit
either
platelet
coagul
cascad
increas
mortal
mice
thu
aspirin
treatment
inhibit
platelet
activ
via
inhibit
cyclooxygenas
subsequ
product
hypothes
worsen
incid
sever
influenza
pandem
taken
togeth
virus
either
enhanc
platelet
activ
result
prothrombot
event
diminish
platelet
respons
therebi
lead
bleed
complic
platelet
count
alon
seem
suffici
predict
advers
platelet
effect
paramet
like
platelet
activ
reactiv
might
accur
predict
thrombot
bleed
risk
patient
platelet
respons
lethal
consequ
cardiovascular
diseas
emerg
evid
suggest
also
play
role
initi
progress
atherosclerosi
sever
virus
associ
cardiovascular
diseas
herp
simplex
viru
hsv
hiv
cmv
hcv
ebv
well
influenza
dna
andor
protein
found
atherosclerot
plaqu
larg
cohort
studi
indic
seroposit
cmv
hcv
repres
independ
risk
marker
cardiovascular
diseas
studi
could
confirm
observ
cmv
hcv
associ
increas
graft
reject
rate
restenosi
follow
coronari
angioplasti
transplant
vascular
sclerosi
indic
latent
viru
reactiv
immunosuppress
contribut
advers
effect
anim
studi
cmv
increas
tlymphocyt
influx
plaqu
neutrophil
extravas
support
presenc
platelet
influenza
viru
infect
correl
acut
coronari
syndrom
myocardi
infarct
influenza
seroposit
cardiovascular
diseas
show
clear
correl
anim
experi
reveal
influenza
trigger
inflammatori
thrombot
respons
atherosclerot
plaqu
revers
protect
role
highdens
lipoprotein
mechan
like
modul
platelet
function
reactiv
discrep
regard
strength
data
regard
hsv
infect
cardiovascular
diseas
despit
proinflammatori
respons
neg
associ
ebv
infect
cardiovascular
diseas
observ
moreov
associ
hiv
infect
cardiovascular
diseas
remain
controversi
antiretrovir
therapi
alter
platelet
function
repres
independ
risk
factor
atherosclerosi
studi
warrant
evalu
contribut
interact
cardiovascular
diseas
platelet
releas
product
report
directli
indirectli
suppress
infect
also
support
viru
persist
respons
certain
virus
make
platelet
doubleedg
sword
viral
infect
platelet
involv
varieti
complic
respons
viral
infect
also
fulfil
pivot
role
retain
adequ
host
respons
thrombocytopenia
common
complic
sever
viral
infect
virus
exert
variou
strategi
mediat
platelet
decay
question
thrombocytopenia
viral
strategi
evad
immun
respons
also
host
protect
function
seem
depend
viru
variant
underli
patholog
studi
warrant
fulli
understand
role
platelet
viral
infect
gain
clear
understand
effect
antiplatelet
therapi
viral
infect
studi
help
us
predict
benefit
drawback
platelet
inhibit
viral
infect
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
